← All diseases Infectious diseases

Chronic hepatitis B

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (82)Meta-analysis (26)Treatment guideline (6)Randomized trial (32)Systematic review (10)Phase 3 study (8)Clinical trial (630)Review article (169)Early study (phase 1 or 2) (25)Description of some patients (97)Laboratory or animal research (16)Commentary or Editorial (50)Retracted publication (2) Studies currently recruiting participants only (31)

Filter

Publications (1405)

• Trust in healthcare providers among Chinese immigrants living with hepatitis B virus in Australia: A qualitative study. (2022/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Metastatic Hepatocellular Carcinoma Masquerading as an Expansile Osteolytic Lesion in Scapula: A Rare Case of Isolated Appendicular Skeletal Metastatic Involvement of Hepatocellular Carcinoma at Initial Presentation. (2022/10/31) ♡
• [Comparison of clinicopathological features for indications of different types of antiviral therapy in chronic hepatitis B]. (2022/10/20) ♡
• [Clinical effect and influencing factors of pegylated interferon alfa-2a and entecavir monotherapy among children with HBeAg-positive chronic hepatitis B based on a real-world study]. (2022/10/20) ♡
• [Sero-epidemiological characteristics of the hepatitis D virus infection among hepatitis B virus infected-patients at a single center in Xinjiang region]. (2022/10/20) ♡
• Effect of pegylated interferon-α2b add-on therapy on renal function in chronic hepatitis B patients: A real-world experience. (2022/10/18) ♡
• Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance. (2022/10/13) ♡
• Improving Long-Term Adherence to Monitoring/Treatment in Underserved Asian Americans with Chronic Hepatitis B (CHB) through a Multicomponent Culturally Tailored Intervention: A Randomized Controlled Trial. (2022/10/05) ♡
• Laryngeal Dysplasia: To Biopsy or Not? (2022/10/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Impact of Fuzheng Huayu tablet on antiviral effect of entecavir in patients with hepatitis B cirrhosis. (2022/10/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Health Within Reach—a Patient-Centered Intervention to Increase Hepatitis B Screening Among Asian Americans: a Randomized Clinical Trial. (2022/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies. (2022/10/01) ♡
• Comparison of the side effects of antivirals in chronic hepatitis B patients: a single-center experience. (2022/10/01) ♡
• Hepatitis B virus PreS2 mutants in liver cancer patients. (2022/09/30) ♡
• Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of Solanum surattense against Hepatocellular Carcinoma. (2022/09/21) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful Novel Treatment of Nonuremic Calciphylaxis with Sodium Thiosulfate and Iloprost: A Case Report. (2022/09/19) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: Comment on "Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: A prospective cohort study". (2022/09/15) ♡
• Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment. (2022/09/15) ♡
• Occult infection with hepatitis B virus PreS variants synergistically promotes hepatocellular carcinoma development in a high-fat diet context by generating abnormal ceramides. (2022/09/05) ♡
• Increased ILT2 expression contributes to dysfunction of CD56(dim)CD16(+)NK cells in chronic hepatitis B virus infection. (2022/09/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Detection & characterization of genotype A1 of hepatitis B virus from central India. (2022/09/01) ♡
• Metabolic-associated fatty liver disease is associated with low muscle mass and strength in patients with chronic hepatitis B. (2022/08/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus. (2022/08/23) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Global epidemiology of occult hepatitis B virus infections in blood donors, a systematic review and meta-analysis. (2022/08/22) ♡
• Targeting lipid biosynthesis pathways for hepatitis B virus cure. (2022/08/04) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: week 144 results from a real-world, multi-centre cohort study. (2022/08/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial. (2022/07/15) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Arthrospira Enhances Seroclearance in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue through Modulation of TNF-α/IFN-γ Profile. (2022/07/06) ♡
• Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B. (2022/07/01) ♡
• The Measurement of 25-Hydroxyvitamin-D in Chronic HBV Patients Using LC-MS/MS. (2022/07/01) ♡
• Evaluation of HBsAg Seroclearance in Patients with Hepatitis B. (2022/07/01) ♡
• Change of Cytokines in Chronic Hepatitis B Patients and HBeAg are Positively Correlated with HBV RNA, Based on Real-world Study. (2022/06/28) ♡
• Hepatitis B Virus Induces Microtubule Stabilization to Promote Productive Infection through Upregulating Microtubule-associated Protein 1S. (2022/06/28) ♡
• Development and Validation of a Nomogram for 90-day Outcome in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure. (2022/06/28) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson's disease like pathology in Zebrafish. (2022/06/28) ♡
• Cascade of care among hepatitis B patients in Maastricht, the Netherlands, 1996 to 2018. (2022/06/20) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Identification of hepatitis B virus genotypes detected in Lahaul & Spiti district of Himachal Pradesh, India. (2022/06/01) ♡
• External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B. (2022/05/25) ♡
• Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection. (2022/05/18) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Risk of HBV reactivation during therapies for HCC: A systematic review. (2022/05/01) ♡
• Unemployment and Illiteracy Are Predictors of Hepatitis B Virus-Related Stigma and Discrimination. (2022/05/01) ♡
• Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase. (2022/04/28) ♡
• Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from China. (2022/04/28) ♡
• A single-cell atlas of diffuse large B cell lymphoma. (2022/04/19) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Examining the Influencing Factors of Chronic Hepatitis B Monitoring Behaviors among Asian Americans: Application of the Information-Motivation-Behavioral Model. (2022/04/12) ♡
• Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection. (2022/04/01) ♡
• Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis. (2022/04/01) ♡
• Comparison of superb microvascular imaging and shear wave elastography for assessing liver fibrosis in chronic hepatitis B. (2022/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study. (2022/04/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Molecular characterization of hepatitis B virus (HBV) isolated from a pediatric case of acute lymphoid leukemia, with a delayed response to antiviral treatment: a case report. (2022/03/31) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.